Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility of Atmo Gas Capsule for Small Intestinal Dysbiosis
NCT04910815Completed
- Sponsor
- Atmo Biosciences
- Start
- Jul 2021
- Primary completion
- Jun 2025
- Countries
- 2
01
Overview
Randomised trial (3 arms), sponsored by Atmo Biosciences. Primary endpoints: Structured Assessment of Gastro-Intestinal Symptoms, Hydrogen fermentation in the small intestine and 1 more. Started Jul 2021; status: completed.
Beyond the preview
Go deeper on NCT04910815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04910815.